During the past decade, Indiana University/Melvin and Bren Simon Cancer Center conducted 221 clinical trials. In the 10-year time frame, 221 clinical trials started and 202 clinical trials were completed, i.e. on average, 91.4% percent of trials that started reached the finish line to date. In the past 5 years, 83 clinical trials started and 85 clinical trials were completed. i.e. 102.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University/Melvin and Bren Simon Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 118 trials, followed by "Children's Oncology Group" with 42 trials sponsored, "Indiana University" with 34 trials sponsored, "Gynecologic Oncology Group" with 25 trials sponsored and "Alliance for Clinical Trials in Oncology" with 25 trials sponsored. Other sponsors include 223 different institutions and companies that sponsored additional 119 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University/Melvin and Bren Simon Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 176 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "Hoosier Cancer Research Network" with 20 trials as a collaborator, "Merck Sharp & Dohme LLC" with 14 trials as a collaborator and "Canadian Cancer Trials Group" with 12 trials as a collaborator. Other collaborators include 199 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University/Melvin and Bren Simon Cancer Center" are "Breast Cancer" (32 trials), "Recurrent Ovarian Carcinoma" (19 trials), "Recurrent Fallopian Tube Carcinoma" (16 trials), "Recurrent Primary Peritoneal Carcinoma" (15 trials) and "Acute Myeloid Leukemia" (11 trials). Many other conditions were trialed in "Indiana University/Melvin and Bren Simon Cancer Center" in a lesser frequency.

Most popular intervention types in "Indiana University/Melvin and Bren Simon Cancer Center" are "Drug" (355 trials), "Other" (193 trials), "Biological" (120 trials), "Procedure" (88 trials) and "Radiation" (74 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (110 trials), "Quality-of-Life Assessment" (58 trials), "Paclitaxel" (43 trials), "Carboplatin" (36 trials) and "Questionnaire Administration" (34 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University/Melvin and Bren Simon Cancer Center" are 346 trials for "All" genders, 95 trials for "Female" genders and 27 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana University/Melvin and Bren Simon Cancer Center". 1 are not yet recruiting, 64 are recruiting, 131 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 197 completed trials in Indiana University/Melvin and Bren Simon Cancer Center, 8 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University/Melvin and Bren Simon Cancer Center, 72 "Phase 1" clinical trials were conducted, 240 "Phase 2" clinical trials and 155 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 28 trials that are defined as “Not Applicable".

Indiana University/Melvin and Bren Simon Cancer Center has several departments that took part in Clinical trials: "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" - 108 trials, "William N. Wishard Memorial Hospital" - 43 trials, "Indiana University School of Dentistry" - 22 trials, "Krannert Institute of Cardiology" - 20 trials, "Indiana University School of Optometry" - 16 trials, "Infectious Diseases Research Center" - 16 trials, "Oral Health Research Institute" - 11 trials, "Indiana University Department of Neurology" - 10 trials, "Indiana Univ Melvin & Bren Simon Cancer Center" - 8 trials, "Indiana University Division of Gastroenterolgy and Hepatology" - 5 trials, "Indiana University School of Medicine, Department of Ophthalmology" - 4 trials, "Children's Health Services Research" - 4 trials, "IU Center for NeuroImaging" - 4 trials, "Eugene and Marilyn Glick Eye Institute" - 3 trials, "Indiana University Department of Radiation Oncology" - 3 trials, "Indiana Center for Vascular Biology and Medicine" - 3 trials, "Indiana University School of Medicine, Outpatient Clinical Research Facility, 535 Barnhill Drive Room #150" - 3 trials, "University Hospital Outpatient Center, Psychiatry" - 3 trials, "Indiana University Cancer Center Clinical Research Office" - 2 trials, "Indiana University - Colon and Rectal" - 2 trials, "IU Simon Cancer Center - Indiana University" - 2 trials, "Riley Hospital for Children/Herman B. Wells Center for Pediatric Research" - 2 trials, "Center for Metabolic and Hormonal Disorders" - 2 trials, "Indiana University, Department of Pediatrics" - 2 trials, "Indiana University Department of Urology" - 2 trials